Dashboard
Manage Tickers

KPRX KIORA PHARMACEUTICALS INC

Nasdaq kiorapharma.com


$ 2.35 $ 0.01 (0.43 %)    

Friday, 07-Nov-2025 15:58:46 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.33
$ 2.26
$ 2.26 x 2
$ 2.40 x 2
$ 2.26 - $ 2.35
$ 2.21 - $ 4.18
11,623
na
8.57M
$ 0.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-25-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-25-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 07-08-2022 03-31-2022 10-Q
16 04-15-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 03-04-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-03-2018 06-30-2018 10-Q
31 05-11-2018 03-31-2018 10-Q
32 03-02-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-04-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-01-2016 09-30-2016 10-Q
38 08-10-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

earnings-scheduled-for-november-7-2025
Earnings Scheduled For November 7, 2025
11/07/2025 11:11:23

kiora-pharmaceuticals-q3-eps-001-may-not-be-comparable-to-066-estimate
Kiora Pharmaceuticals Q3 EPS $0.01 May Not...
11/07/2025 11:10:27

kiora-pharmaceuticals-joins-global-genes-rare-x-vision-consortium-a-corporate-nonprofit-initiative-aimed-at-advancing-research-for-rare-ocular-disorders
Kiora Pharmaceuticals Joins Global Genes' ...
10/30/2025 13:07:39

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) and Global Genes today announced that Kiora has joined Global Genes' RARE-X Visio...

kiora-pharmaceuticals-files-for-100m-mixed-shelf-offering
Kiora Pharmaceuticals Files For $100M Mixe...
09/15/2025 20:26:02

https://www.sec.gov/Archives/edgar/data/1372514/000137251425000072/s-3xseptember2025.htm

hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Kior...
09/02/2025 11:14:11

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

kiora-pharmaceuticals-ended-q2-with-207m-in-cash-cash-equivalents-and-short-term-investments-along-with-24m-in-collaboration-receivables-and-07m-in-research-incentive-tax-credits-with-projected-cash-runway-into-late-2027
Kiora Pharmaceuticals Ended Q2 With $20.7M...
08/08/2025 11:17:22

kiora-pharmaceuticals-q2-eps-054-beats-060-estimate
Kiora Pharmaceuticals Q2 EPS $(0.54) Beats...
08/08/2025 11:12:20

kiora-pharmaceuticals-granted-us-patent-expanding-protection-for-kio-104-in-the-treatment-of-ocular-disease
Kiora Pharmaceuticals Granted U.S. Patent ...
07/22/2025 13:09:11

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 12:07:39

kiora-grants-senju-option-to-develop-and-market-vision-restoring-drug-kio-301-in-asia
Kiora Grants Senju Option to Develop and M...
06/03/2025 11:05:34

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company") today announced it has granted Senju Pharm...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/16/2025 21:05:42

hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Kior...
03/28/2025 10:32:09

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

kiora-gets-approval-to-begin-klarity-a-phase-2-clinical-trial-to-investigate-kio-104-in-patients-with-retinal-macular-edem
Kiora Gets Approval To Begin KLARITY, A Ph...
02/11/2025 11:49:29

hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Kior...
11/12/2024 10:06:16

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Kior...
08/22/2024 16:28:29

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-10-1-9-reverse-stock-split
HC Wainwright & Co. Maintains Buy on Kiora...
07/23/2024 17:37:42

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $10 from $2...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
06/11/2024 12:55:05

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/10/2024 23:50:03

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/06/2024 20:31:11

hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-2-price-target
HC Wainwright & Co. Reiterates Buy on Kior...
05/20/2024 11:19:36

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION